Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007*-Reference-Cited by-同舟云学术

Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007*

Published:2010-05-21 Issue:8 Volume:27 Page:938-948
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:

Author:

Currie C. J.,Gale E. A. M.,Poole C. D.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.2010.03040.x/fullpdf

Reference26 articles.

1. NHS acute sector expenditure for diabetes: the present, future, and excess in-patient cost of care;Currie;Diabet Med,1997

2. The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060;Bagust;Diabet Med,2002

3. Estimated costs of acute hospital care for people with diabetes in the United Kingdom: a routine record linkage study in a large region;Morgan;Diabet Med

4. The changing prevalence of diagnosed diabetes and its associated vascular complications in a health district of the United Kingdom;Morgan;Diabet Med,2010

5. Dispensing patterns and financial costs of glucose lowering therapies in the United Kingdom from 2000 to 2008;Currie;Diabet Med,2010

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Long-Term Cost-Effectiveness of the English NHS Diabetes Prevention Programme using a Markov Model;PharmacoEconomics - Open;2024-04-20

2. The burden of type 2 diabetes mellitus in states of the European Union and United Kingdom at the national and subnational levels: A systematic review;Obesity Reviews;2023-07-04

3. REVIEW ON CO-MORBIDITIES IN DIABETES MELLITUS;International Journal of Current Innovations in Advanced Research;2023-03-24

4. Direct healthcare costs of Rome IV or Rome III ‐defined irritable bowel syndrome in the United Kingdom;Alimentary Pharmacology & Therapeutics;2022-05

5. On the survival of individuals diagnosed with type 2 diabetes mellitus in the United Kingdom: A retrospective matched cohort study;Diabetes Epidemiology and Management;2022-04